Phase II study of short-course capecitabine plus oxaliplatin (XELOX) followed by maintenance capecitabine in advanced colorectal cancer: XelQuali study. [electronic resource]
Producer: 20110623Description: 1111-7 p. digitalISSN:- 1432-0843
- Adult
- Aged
- Antimetabolites, Antineoplastic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Capecitabine
- Colorectal Neoplasms -- drug therapy
- Deoxycytidine -- administration & dosage
- Female
- Fluorouracil -- administration & dosage
- Humans
- Male
- Middle Aged
- Neoplasm Metastasis
- Organoplatinum Compounds -- administration & dosage
- Oxaliplatin
- Quality of Life
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.